Trial intelligence / Profile preview

Etoricoxib vs Diclofenac in Chinese Patients with Osteoarthritis

NCT00140972Phase 4Completed

Sponsor
Organon & Co.
Start
Dec 2004
Primary completion
Jun 2005
Modality
Small Molecules
01

Overview

A Phase 4 trial of etoricoxib in osteoarthritis (OA), sponsored by Organon & Co.. Started Dec 2004; status: completed.

02

Drugs

etoricoxib
03

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on NCT00140972.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00140972.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call